Prediction	O
of	O
Estrogenic	B:C0014939
Bioactivity	O
of	O
Environmental	O
Chemical	I:C0220806
Metabolites	O
.	O

Prediction	O
of	O
Estrogenic	O
Bioactivity	O
of	O
Environmental	B:C0220806
Chemical	I:C0220806
Metabolites	O
.	O

Prediction	O
of	O
Estrogenic	O
Bioactivity	O
of	O
Environmental	O
Chemical	I:C0220806
Metabolites	B:C0870883
.	O

The	O
US	B:C0041712
Environmental	I:C0041712
Protection	I:C0041712
Agency's	I:C0041712
(	O
Environmental	O
Protection	I:C0041712
Agency's	I:C0041712
)	O
Endocrine	O
Disruptor	O
Screening	O
Program	O
(	O
EDSP	O
)	O
is	O
using	O
in	O
vitro	O
data	O
generated	O
from	O
ToxCast	O
/	O
Tox21	O
high	O
-	I:C2718002
throughput	I:C2718002
screening	I:C2718002
assays	I:C2718002
to	O
assess	O
the	O
endocrine	O
activity	O
of	O
environmental	O
chemicals	I:C0220806
.	O

The	O
US	O
Environmental	I:C0041712
Protection	I:C0041712
Agency's	I:C0041712
(	O
Environmental	B:C0041712
Protection	I:C0041712
Agency's	I:C0041712
)	O
Endocrine	O
Disruptor	O
Screening	O
Program	O
(	O
EDSP	O
)	O
is	O
using	O
in	O
vitro	O
data	O
generated	O
from	O
ToxCast	O
/	O
Tox21	O
high	O
-	I:C2718002
throughput	I:C2718002
screening	I:C2718002
assays	I:C2718002
to	O
assess	O
the	O
endocrine	O
activity	O
of	O
environmental	O
chemicals	I:C0220806
.	O

The	O
US	O
Environmental	I:C0041712
Protection	I:C0041712
Agency's	I:C0041712
(	O
Environmental	O
Protection	I:C0041712
Agency's	I:C0041712
)	O
Endocrine	O
Disruptor	O
Screening	O
Program	O
(	O
EDSP	O
)	O
is	O
using	O
in	O
vitro	O
data	O
generated	O
from	O
ToxCast	B:C0282574
/	O
Tox21	O
high	O
-	I:C2718002
throughput	I:C2718002
screening	I:C2718002
assays	I:C2718002
to	O
assess	O
the	O
endocrine	O
activity	O
of	O
environmental	O
chemicals	I:C0220806
.	O

The	O
US	O
Environmental	I:C0041712
Protection	I:C0041712
Agency's	I:C0041712
(	O
Environmental	O
Protection	I:C0041712
Agency's	I:C0041712
)	O
Endocrine	O
Disruptor	O
Screening	O
Program	O
(	O
EDSP	O
)	O
is	O
using	O
in	O
vitro	O
data	O
generated	O
from	O
ToxCast	O
/	O
Tox21	B:C0282574
high	O
-	I:C2718002
throughput	I:C2718002
screening	I:C2718002
assays	I:C2718002
to	O
assess	O
the	O
endocrine	O
activity	O
of	O
environmental	O
chemicals	I:C0220806
.	O

The	O
US	O
Environmental	I:C0041712
Protection	I:C0041712
Agency's	I:C0041712
(	O
Environmental	O
Protection	I:C0041712
Agency's	I:C0041712
)	O
Endocrine	O
Disruptor	O
Screening	O
Program	O
(	O
EDSP	O
)	O
is	O
using	O
in	O
vitro	O
data	O
generated	O
from	O
ToxCast	O
/	O
Tox21	O
high	B:C2718002
-	I:C2718002
throughput	I:C2718002
screening	I:C2718002
assays	I:C2718002
to	O
assess	O
the	O
endocrine	O
activity	O
of	O
environmental	O
chemicals	I:C0220806
.	O

The	O
US	O
Environmental	I:C0041712
Protection	I:C0041712
Agency's	I:C0041712
(	O
Environmental	O
Protection	I:C0041712
Agency's	I:C0041712
)	O
Endocrine	O
Disruptor	O
Screening	O
Program	O
(	O
EDSP	O
)	O
is	O
using	O
in	O
vitro	O
data	O
generated	O
from	O
ToxCast	O
/	O
Tox21	O
high	O
-	I:C2718002
throughput	I:C2718002
screening	I:C2718002
assays	I:C2718002
to	O
assess	O
the	O
endocrine	B:C0014136
activity	O
of	O
environmental	O
chemicals	I:C0220806
.	O

The	O
US	O
Environmental	I:C0041712
Protection	I:C0041712
Agency's	I:C0041712
(	O
Environmental	O
Protection	I:C0041712
Agency's	I:C0041712
)	O
Endocrine	O
Disruptor	O
Screening	O
Program	O
(	O
EDSP	O
)	O
is	O
using	O
in	O
vitro	O
data	O
generated	O
from	O
ToxCast	O
/	O
Tox21	O
high	O
-	I:C2718002
throughput	I:C2718002
screening	I:C2718002
assays	I:C2718002
to	O
assess	O
the	O
endocrine	O
activity	O
of	O
environmental	B:C0220806
chemicals	I:C0220806
.	O

Considering	O
that	O
in	B:C3850137
vitro	I:C3850137
assays	I:C3850137
may	O
have	O
limited	O
metabolic	O
capacity	O
,	O
inactive	O
chemicals	I:C0220806
that	O
are	O
biotransformed	O
into	O
metabolites	O
with	O
endocrine	O
bioactivity	O
may	O
be	O
missed	O
for	O
further	O
screening	O
and	O
testing	O
.	O

Considering	O
that	O
in	O
vitro	I:C3850137
assays	I:C3850137
may	O
have	O
limited	O
metabolic	O
capacity	O
,	O
inactive	B:C0220806
chemicals	I:C0220806
that	O
are	O
biotransformed	O
into	O
metabolites	O
with	O
endocrine	O
bioactivity	O
may	O
be	O
missed	O
for	O
further	O
screening	O
and	O
testing	O
.	O

Considering	O
that	O
in	O
vitro	I:C3850137
assays	I:C3850137
may	O
have	O
limited	O
metabolic	O
capacity	O
,	O
inactive	O
chemicals	I:C0220806
that	O
are	O
biotransformed	B:C0005576
into	O
metabolites	O
with	O
endocrine	O
bioactivity	O
may	O
be	O
missed	O
for	O
further	O
screening	O
and	O
testing	O
.	O

Considering	O
that	O
in	O
vitro	I:C3850137
assays	I:C3850137
may	O
have	O
limited	O
metabolic	O
capacity	O
,	O
inactive	O
chemicals	I:C0220806
that	O
are	O
biotransformed	O
into	O
metabolites	B:C0870883
with	O
endocrine	O
bioactivity	O
may	O
be	O
missed	O
for	O
further	O
screening	O
and	O
testing	O
.	O

Considering	O
that	O
in	O
vitro	I:C3850137
assays	I:C3850137
may	O
have	O
limited	O
metabolic	O
capacity	O
,	O
inactive	O
chemicals	I:C0220806
that	O
are	O
biotransformed	O
into	O
metabolites	O
with	O
endocrine	B:C0014136
bioactivity	O
may	O
be	O
missed	O
for	O
further	O
screening	O
and	O
testing	O
.	O

Therefore	O
,	O
there	O
is	O
a	O
value	O
in	O
developing	O
novel	O
approaches	O
to	O
account	O
for	O
metabolism	B:C0025519
and	O
endocrine	O
activity	O
of	O
both	O
parent	O
chemicals	I:C0220806
and	O
their	O
associated	O
metabolites	O
.	O

Therefore	O
,	O
there	O
is	O
a	O
value	O
in	O
developing	O
novel	O
approaches	O
to	O
account	O
for	O
metabolism	O
and	O
endocrine	B:C0014136
activity	O
of	O
both	O
parent	O
chemicals	I:C0220806
and	O
their	O
associated	O
metabolites	O
.	O

Therefore	O
,	O
there	O
is	O
a	O
value	O
in	O
developing	O
novel	O
approaches	O
to	O
account	O
for	O
metabolism	O
and	O
endocrine	O
activity	O
of	O
both	O
parent	B:C0220806
chemicals	I:C0220806
and	O
their	O
associated	O
metabolites	O
.	O

Therefore	O
,	O
there	O
is	O
a	O
value	O
in	O
developing	O
novel	O
approaches	O
to	O
account	O
for	O
metabolism	O
and	O
endocrine	O
activity	O
of	O
both	O
parent	O
chemicals	I:C0220806
and	O
their	O
associated	O
metabolites	B:C0870883
.	O

We	O
used	O
commercially	O
available	O
software	B:C0037585
to	O
predict	O
metabolites	O
of	O
50	O
parent	O
compounds	I:C1706082
,	O
out	O
of	O
which	O
38	O
chemicals	O
are	O
known	O
to	O
have	O
estrogenic	O
metabolites	O
,	O
and	O
12	O
compounds	O
and	O
their	O
metabolites	O
are	O
negative	O
for	O
estrogenic	O
activity	O
.	O

We	O
used	O
commercially	O
available	O
software	O
to	O
predict	O
metabolites	B:C0870883
of	O
50	O
parent	O
compounds	I:C1706082
,	O
out	O
of	O
which	O
38	O
chemicals	O
are	O
known	O
to	O
have	O
estrogenic	O
metabolites	O
,	O
and	O
12	O
compounds	O
and	O
their	O
metabolites	O
are	O
negative	O
for	O
estrogenic	O
activity	O
.	O

We	O
used	O
commercially	O
available	O
software	O
to	O
predict	O
metabolites	O
of	O
50	O
parent	B:C1706082
compounds	I:C1706082
,	O
out	O
of	O
which	O
38	O
chemicals	O
are	O
known	O
to	O
have	O
estrogenic	O
metabolites	O
,	O
and	O
12	O
compounds	O
and	O
their	O
metabolites	O
are	O
negative	O
for	O
estrogenic	O
activity	O
.	O

We	O
used	O
commercially	O
available	O
software	O
to	O
predict	O
metabolites	O
of	O
50	O
parent	O
compounds	I:C1706082
,	O
out	O
of	O
which	O
38	O
chemicals	B:C0220806
are	O
known	O
to	O
have	O
estrogenic	O
metabolites	O
,	O
and	O
12	O
compounds	O
and	O
their	O
metabolites	O
are	O
negative	O
for	O
estrogenic	O
activity	O
.	O

We	O
used	O
commercially	O
available	O
software	O
to	O
predict	O
metabolites	O
of	O
50	O
parent	O
compounds	I:C1706082
,	O
out	O
of	O
which	O
38	O
chemicals	O
are	O
known	O
to	O
have	O
estrogenic	B:C0014939
metabolites	O
,	O
and	O
12	O
compounds	O
and	O
their	O
metabolites	O
are	O
negative	O
for	O
estrogenic	O
activity	O
.	O

We	O
used	O
commercially	O
available	O
software	O
to	O
predict	O
metabolites	O
of	O
50	O
parent	O
compounds	I:C1706082
,	O
out	O
of	O
which	O
38	O
chemicals	O
are	O
known	O
to	O
have	O
estrogenic	O
metabolites	B:C0870883
,	O
and	O
12	O
compounds	O
and	O
their	O
metabolites	O
are	O
negative	O
for	O
estrogenic	O
activity	O
.	O

We	O
used	O
commercially	O
available	O
software	O
to	O
predict	O
metabolites	O
of	O
50	O
parent	O
compounds	I:C1706082
,	O
out	O
of	O
which	O
38	O
chemicals	O
are	O
known	O
to	O
have	O
estrogenic	O
metabolites	O
,	O
and	O
12	O
compounds	B:C1706082
and	O
their	O
metabolites	O
are	O
negative	O
for	O
estrogenic	O
activity	O
.	O

We	O
used	O
commercially	O
available	O
software	O
to	O
predict	O
metabolites	O
of	O
50	O
parent	O
compounds	I:C1706082
,	O
out	O
of	O
which	O
38	O
chemicals	O
are	O
known	O
to	O
have	O
estrogenic	O
metabolites	O
,	O
and	O
12	O
compounds	O
and	O
their	O
metabolites	B:C0870883
are	O
negative	O
for	O
estrogenic	O
activity	O
.	O

We	O
used	O
commercially	O
available	O
software	O
to	O
predict	O
metabolites	O
of	O
50	O
parent	O
compounds	I:C1706082
,	O
out	O
of	O
which	O
38	O
chemicals	O
are	O
known	O
to	O
have	O
estrogenic	O
metabolites	O
,	O
and	O
12	O
compounds	O
and	O
their	O
metabolites	O
are	O
negative	O
for	O
estrogenic	B:C0014939
activity	O
.	O

Three	O
ER	B:C0034804
QSAR	O
models	O
were	O
used	O
to	O
determine	O
potential	O
estrogen	O
bioactivity	O
of	O
the	O
parent	O
compounds	I:C1706082
and	O
predicted	O
metabolites	O
,	O
the	O
outputs	O
of	O
the	O
models	O
were	O
averaged	O
,	O
and	O
the	O
chemicals	O
were	O
then	O
ranked	O
based	O
on	O
the	O
total	O
estrogenicity	O
of	O
the	O
parent	O
chemical	I:C0220806
and	O
metabolites	O
.	O

Three	O
ER	O
QSAR	O
models	B:C3161035
were	O
used	O
to	O
determine	O
potential	O
estrogen	O
bioactivity	O
of	O
the	O
parent	O
compounds	I:C1706082
and	O
predicted	O
metabolites	O
,	O
the	O
outputs	O
of	O
the	O
models	O
were	O
averaged	O
,	O
and	O
the	O
chemicals	O
were	O
then	O
ranked	O
based	O
on	O
the	O
total	O
estrogenicity	O
of	O
the	O
parent	O
chemical	I:C0220806
and	O
metabolites	O
.	O

Three	O
ER	O
QSAR	O
models	O
were	O
used	O
to	O
determine	O
potential	O
estrogen	B:C0014939
bioactivity	O
of	O
the	O
parent	O
compounds	I:C1706082
and	O
predicted	O
metabolites	O
,	O
the	O
outputs	O
of	O
the	O
models	O
were	O
averaged	O
,	O
and	O
the	O
chemicals	O
were	O
then	O
ranked	O
based	O
on	O
the	O
total	O
estrogenicity	O
of	O
the	O
parent	O
chemical	I:C0220806
and	O
metabolites	O
.	O

Three	O
ER	O
QSAR	O
models	O
were	O
used	O
to	O
determine	O
potential	O
estrogen	O
bioactivity	O
of	O
the	O
parent	B:C1706082
compounds	I:C1706082
and	O
predicted	O
metabolites	O
,	O
the	O
outputs	O
of	O
the	O
models	O
were	O
averaged	O
,	O
and	O
the	O
chemicals	O
were	O
then	O
ranked	O
based	O
on	O
the	O
total	O
estrogenicity	O
of	O
the	O
parent	O
chemical	I:C0220806
and	O
metabolites	O
.	O

Three	O
ER	O
QSAR	O
models	O
were	O
used	O
to	O
determine	O
potential	O
estrogen	O
bioactivity	O
of	O
the	O
parent	O
compounds	I:C1706082
and	O
predicted	O
metabolites	B:C0870883
,	O
the	O
outputs	O
of	O
the	O
models	O
were	O
averaged	O
,	O
and	O
the	O
chemicals	O
were	O
then	O
ranked	O
based	O
on	O
the	O
total	O
estrogenicity	O
of	O
the	O
parent	O
chemical	I:C0220806
and	O
metabolites	O
.	O

Three	O
ER	O
QSAR	O
models	O
were	O
used	O
to	O
determine	O
potential	O
estrogen	O
bioactivity	O
of	O
the	O
parent	O
compounds	I:C1706082
and	O
predicted	O
metabolites	O
,	O
the	O
outputs	O
of	O
the	O
models	B:C3161035
were	O
averaged	O
,	O
and	O
the	O
chemicals	O
were	O
then	O
ranked	O
based	O
on	O
the	O
total	O
estrogenicity	O
of	O
the	O
parent	O
chemical	I:C0220806
and	O
metabolites	O
.	O

Three	O
ER	O
QSAR	O
models	O
were	O
used	O
to	O
determine	O
potential	O
estrogen	O
bioactivity	O
of	O
the	O
parent	O
compounds	I:C1706082
and	O
predicted	O
metabolites	O
,	O
the	O
outputs	O
of	O
the	O
models	O
were	O
averaged	O
,	O
and	O
the	O
chemicals	B:C0220806
were	O
then	O
ranked	O
based	O
on	O
the	O
total	O
estrogenicity	O
of	O
the	O
parent	O
chemical	I:C0220806
and	O
metabolites	O
.	O

Three	O
ER	O
QSAR	O
models	O
were	O
used	O
to	O
determine	O
potential	O
estrogen	O
bioactivity	O
of	O
the	O
parent	O
compounds	I:C1706082
and	O
predicted	O
metabolites	O
,	O
the	O
outputs	O
of	O
the	O
models	O
were	O
averaged	O
,	O
and	O
the	O
chemicals	O
were	O
then	O
ranked	O
based	O
on	O
the	O
total	O
estrogenicity	O
of	O
the	O
parent	B:C0220806
chemical	I:C0220806
and	O
metabolites	O
.	O

Three	O
ER	O
QSAR	O
models	O
were	O
used	O
to	O
determine	O
potential	O
estrogen	O
bioactivity	O
of	O
the	O
parent	O
compounds	I:C1706082
and	O
predicted	O
metabolites	O
,	O
the	O
outputs	O
of	O
the	O
models	O
were	O
averaged	O
,	O
and	O
the	O
chemicals	O
were	O
then	O
ranked	O
based	O
on	O
the	O
total	O
estrogenicity	O
of	O
the	O
parent	O
chemical	I:C0220806
and	O
metabolites	B:C0870883
.	O

The	O
metabolite	B:C0037585
prediction	I:C0037585
software	I:C0037585
correctly	O
identified	O
known	O
estrogenic	O
metabolites	O
for	O
26	O
out	O
of	O
27	O
parent	O
chemicals	I:C0220806
with	O
associated	O
metabolite	O
data	O
,	O
and	O
39	O
out	O
of	O
46	O
estrogenic	O
metabolites	O
were	O
predicted	O
as	O
potential	O
biotransformation	O
products	O
derived	O
from	O
the	O
parent	O
chemical	I:C0220806
.	O

The	O
metabolite	O
prediction	I:C0037585
software	I:C0037585
correctly	O
identified	O
known	O
estrogenic	B:C0014939
metabolites	O
for	O
26	O
out	O
of	O
27	O
parent	O
chemicals	I:C0220806
with	O
associated	O
metabolite	O
data	O
,	O
and	O
39	O
out	O
of	O
46	O
estrogenic	O
metabolites	O
were	O
predicted	O
as	O
potential	O
biotransformation	O
products	O
derived	O
from	O
the	O
parent	O
chemical	I:C0220806
.	O

The	O
metabolite	O
prediction	I:C0037585
software	I:C0037585
correctly	O
identified	O
known	O
estrogenic	O
metabolites	B:C0870883
for	O
26	O
out	O
of	O
27	O
parent	O
chemicals	I:C0220806
with	O
associated	O
metabolite	O
data	O
,	O
and	O
39	O
out	O
of	O
46	O
estrogenic	O
metabolites	O
were	O
predicted	O
as	O
potential	O
biotransformation	O
products	O
derived	O
from	O
the	O
parent	O
chemical	I:C0220806
.	O

The	O
metabolite	O
prediction	I:C0037585
software	I:C0037585
correctly	O
identified	O
known	O
estrogenic	O
metabolites	O
for	O
26	O
out	O
of	O
27	O
parent	B:C0220806
chemicals	I:C0220806
with	O
associated	O
metabolite	O
data	O
,	O
and	O
39	O
out	O
of	O
46	O
estrogenic	O
metabolites	O
were	O
predicted	O
as	O
potential	O
biotransformation	O
products	O
derived	O
from	O
the	O
parent	O
chemical	I:C0220806
.	O

The	O
metabolite	O
prediction	I:C0037585
software	I:C0037585
correctly	O
identified	O
known	O
estrogenic	O
metabolites	O
for	O
26	O
out	O
of	O
27	O
parent	O
chemicals	I:C0220806
with	O
associated	O
metabolite	B:C0870883
data	O
,	O
and	O
39	O
out	O
of	O
46	O
estrogenic	O
metabolites	O
were	O
predicted	O
as	O
potential	O
biotransformation	O
products	O
derived	O
from	O
the	O
parent	O
chemical	I:C0220806
.	O

The	O
metabolite	O
prediction	I:C0037585
software	I:C0037585
correctly	O
identified	O
known	O
estrogenic	O
metabolites	O
for	O
26	O
out	O
of	O
27	O
parent	O
chemicals	I:C0220806
with	O
associated	O
metabolite	O
data	O
,	O
and	O
39	O
out	O
of	O
46	O
estrogenic	B:C0014939
metabolites	O
were	O
predicted	O
as	O
potential	O
biotransformation	O
products	O
derived	O
from	O
the	O
parent	O
chemical	I:C0220806
.	O

The	O
metabolite	O
prediction	I:C0037585
software	I:C0037585
correctly	O
identified	O
known	O
estrogenic	O
metabolites	O
for	O
26	O
out	O
of	O
27	O
parent	O
chemicals	I:C0220806
with	O
associated	O
metabolite	O
data	O
,	O
and	O
39	O
out	O
of	O
46	O
estrogenic	O
metabolites	B:C0870883
were	O
predicted	O
as	O
potential	O
biotransformation	O
products	O
derived	O
from	O
the	O
parent	O
chemical	I:C0220806
.	O

The	O
metabolite	O
prediction	I:C0037585
software	I:C0037585
correctly	O
identified	O
known	O
estrogenic	O
metabolites	O
for	O
26	O
out	O
of	O
27	O
parent	O
chemicals	I:C0220806
with	O
associated	O
metabolite	O
data	O
,	O
and	O
39	O
out	O
of	O
46	O
estrogenic	O
metabolites	O
were	O
predicted	O
as	O
potential	O
biotransformation	B:C0005576
products	O
derived	O
from	O
the	O
parent	O
chemical	I:C0220806
.	O

The	O
metabolite	O
prediction	I:C0037585
software	I:C0037585
correctly	O
identified	O
known	O
estrogenic	O
metabolites	O
for	O
26	O
out	O
of	O
27	O
parent	O
chemicals	I:C0220806
with	O
associated	O
metabolite	O
data	O
,	O
and	O
39	O
out	O
of	O
46	O
estrogenic	O
metabolites	O
were	O
predicted	O
as	O
potential	O
biotransformation	O
products	B:C0005522
derived	O
from	O
the	O
parent	O
chemical	I:C0220806
.	O

The	O
metabolite	O
prediction	I:C0037585
software	I:C0037585
correctly	O
identified	O
known	O
estrogenic	O
metabolites	O
for	O
26	O
out	O
of	O
27	O
parent	O
chemicals	I:C0220806
with	O
associated	O
metabolite	O
data	O
,	O
and	O
39	O
out	O
of	O
46	O
estrogenic	O
metabolites	O
were	O
predicted	O
as	O
potential	O
biotransformation	O
products	O
derived	O
from	O
the	O
parent	B:C0220806
chemical	I:C0220806
.	O

The	O
QSAR	O
models	B:C3161035
estimated	O
stronger	O
estrogenic	O
activity	O
for	O
the	O
majority	O
of	O
the	O
known	O
estrogenic	O
metabolites	O
compared	O
to	O
their	O
parent	O
chemicals	I:C0220806
.	O

The	O
QSAR	O
models	O
estimated	O
stronger	O
estrogenic	B:C0014939
activity	O
for	O
the	O
majority	O
of	O
the	O
known	O
estrogenic	O
metabolites	O
compared	O
to	O
their	O
parent	O
chemicals	I:C0220806
.	O

The	O
QSAR	O
models	O
estimated	O
stronger	O
estrogenic	O
activity	O
for	O
the	O
majority	O
of	O
the	O
known	O
estrogenic	B:C0014939
metabolites	O
compared	O
to	O
their	O
parent	O
chemicals	I:C0220806
.	O

The	O
QSAR	O
models	O
estimated	O
stronger	O
estrogenic	O
activity	O
for	O
the	O
majority	O
of	O
the	O
known	O
estrogenic	O
metabolites	B:C0870883
compared	O
to	O
their	O
parent	O
chemicals	I:C0220806
.	O

The	O
QSAR	O
models	O
estimated	O
stronger	O
estrogenic	O
activity	O
for	O
the	O
majority	O
of	O
the	O
known	O
estrogenic	O
metabolites	O
compared	O
to	O
their	O
parent	B:C0220806
chemicals	I:C0220806
.	O

Finally	O
,	O
the	O
three	O
models	B:C3161035
identified	O
a	O
similar	O
set	O
of	O
parent	O
compounds	I:C1706082
as	O
top	O
ranked	O
chemicals	O
based	O
on	O
the	O
estrogenicity	O
of	O
putative	O
metabolites	O
.	O

Finally	O
,	O
the	O
three	O
models	O
identified	O
a	O
similar	O
set	O
of	O
parent	B:C1706082
compounds	I:C1706082
as	O
top	O
ranked	O
chemicals	O
based	O
on	O
the	O
estrogenicity	O
of	O
putative	O
metabolites	O
.	O

Finally	O
,	O
the	O
three	O
models	O
identified	O
a	O
similar	O
set	O
of	O
parent	O
compounds	I:C1706082
as	O
top	O
ranked	O
chemicals	B:C0220806
based	O
on	O
the	O
estrogenicity	O
of	O
putative	O
metabolites	O
.	O

Finally	O
,	O
the	O
three	O
models	O
identified	O
a	O
similar	O
set	O
of	O
parent	O
compounds	I:C1706082
as	O
top	O
ranked	O
chemicals	O
based	O
on	O
the	O
estrogenicity	O
of	O
putative	O
metabolites	B:C0870883
.	O

This	O
proposed	O
in	O
silico	O
approach	O
is	O
an	O
inexpensive	O
and	O
rapid	O
strategy	O
for	O
the	O
detection	B:C0442726
of	O
chemicals	O
with	O
estrogenic	O
metabolites	O
and	O
may	O
reduce	O
potential	O
false	O
negative	I:C0205558
results	O
from	O
in	O
vitro	I:C3850137
assays	I:C3850137
.	O

This	O
proposed	O
in	O
silico	O
approach	O
is	O
an	O
inexpensive	O
and	O
rapid	O
strategy	O
for	O
the	O
detection	O
of	O
chemicals	B:C0220806
with	O
estrogenic	O
metabolites	O
and	O
may	O
reduce	O
potential	O
false	O
negative	I:C0205558
results	O
from	O
in	O
vitro	I:C3850137
assays	I:C3850137
.	O

This	O
proposed	O
in	O
silico	O
approach	O
is	O
an	O
inexpensive	O
and	O
rapid	O
strategy	O
for	O
the	O
detection	O
of	O
chemicals	O
with	O
estrogenic	B:C0014939
metabolites	O
and	O
may	O
reduce	O
potential	O
false	O
negative	I:C0205558
results	O
from	O
in	O
vitro	I:C3850137
assays	I:C3850137
.	O

This	O
proposed	O
in	O
silico	O
approach	O
is	O
an	O
inexpensive	O
and	O
rapid	O
strategy	O
for	O
the	O
detection	O
of	O
chemicals	O
with	O
estrogenic	O
metabolites	B:C0870883
and	O
may	O
reduce	O
potential	O
false	O
negative	I:C0205558
results	O
from	O
in	O
vitro	I:C3850137
assays	I:C3850137
.	O

This	O
proposed	O
in	O
silico	O
approach	O
is	O
an	O
inexpensive	O
and	O
rapid	O
strategy	O
for	O
the	O
detection	O
of	O
chemicals	O
with	O
estrogenic	O
metabolites	O
and	O
may	O
reduce	O
potential	O
false	B:C0205558
negative	I:C0205558
results	O
from	O
in	O
vitro	I:C3850137
assays	I:C3850137
.	O

This	O
proposed	O
in	O
silico	O
approach	O
is	O
an	O
inexpensive	O
and	O
rapid	O
strategy	O
for	O
the	O
detection	O
of	O
chemicals	O
with	O
estrogenic	O
metabolites	O
and	O
may	O
reduce	O
potential	O
false	O
negative	I:C0205558
results	O
from	O
in	B:C3850137
vitro	I:C3850137
assays	I:C3850137
.	O

